UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
PagerDuty
PD
$902M
| $5.95M | ﹤0.01% |
389,558
+109,617
| +39% | +$1.7M |
|
1627
Green Brick Partners
GRBK
$3.14B
| $5.95M | ﹤0.01% |
94,632
+29,035
| +44% | +$1.72M |
|
1628
Alignment Healthcare
ALHC
$2.98B
| $5.94M | ﹤0.01% |
424,624
+116,969
| +38% | +$1.88M |
|
1629
Strategic Education
STRA
$1.92B
| $5.94M | ﹤0.01% |
69,750
+24,655
| +55% | +$2.1M |
|
1630
Arbe Robotics
ARBE
$94.2M
| $5.94M | ﹤0.01% |
3,334,563
-1,514,591
| -31% | -$2.16M |
|
1631
Alkami Technology
ALKT
$2.11B
| $5.93M | ﹤0.01% |
196,853
+75,362
| +62% | +$2.09M |
|
1632
Enovix
ENVX
$1.03B
| $5.93M | ﹤0.01% |
655,169
+246,000
| +60% | +$1.6M |
|
1633
Sotera Health
SHC
$5.38B
| $5.92M | ﹤0.01% |
532,347
+189,413
| +55% | +$2.22M |
|
1634
DigitalOcean
DOCN
$14.6B
| $5.9M | ﹤0.01% |
206,535
-133,135
| -39% | -$3.89M |
|
1635
CONMED
CNMD
$1.47B
| $5.89M | ﹤0.01% |
113,063
+30,377
| +37% | +$1.67M |
|
1636
Pediatrix Medical
MD
$2.2B
| $5.85M | ﹤0.01% |
407,863
+139,357
| +52% | +$1.91M |
|
1637
Tennant Co
TNC
$1.26B
| $5.85M | ﹤0.01% |
75,524
+19,310
| +34% | +$1.43M |
|
1638
Boston Beer
SAM
$1.92B
| $5.83M | ﹤0.01% |
30,565
+8,663
| +40% | +$1.99M |
|
1639
Teladoc Health
TDOC
$1.3B
| $5.83M | ﹤0.01% |
669,529
+221,537
| +49% | +$1.61M |
|
1640
Alamos Gold
AGI
$13.9B
| $5.83M | ﹤0.01% |
219,320
-794,546
| -78% | -$21.2M |
|
1641
NewAmsterdam Pharma
NAMS
$3.34B
| $5.81M | ﹤0.01% |
320,804
+32,670
| +11% | +$596K |
|
1642
Liberty Broadband Class A
LBRDA
$5.16B
| $5.81M | ﹤0.01% |
59,350
+18,554
| +45% | +$1.65M |
|
1643
A10 Networks
ATEN
$1.95B
| $5.79M | ﹤0.01% |
299,479
+96,821
| +48% | +$1.65M |
|
1644
Phinia Inc
PHIN
$2.74B
| $5.78M | ﹤0.01% |
129,959
+35,689
| +38% | +$1.51M |
|
1645
Liberty Live Group Series A
LLYVA
$9.09B
| $5.77M | ﹤0.01% |
72,586
+16,337
| +29% | +$1.19M |
|
1646
Azenta
AZTA
$1.48B
| $5.77M | ﹤0.01% |
187,342
-13,995
| -7% | -$394K |
|
1647
Colliers International
CIGI
$5.19B
| $5.75M | ﹤0.01% |
44,053
-1,355
| -3% | -$165K |
|
1648
J&J Snack Foods
JJSF
$1.71B
| $5.73M | ﹤0.01% |
50,542
+17,116
| +51% | +$2.08M |
|
1649
IDEAYA Biosciences
IDYA
$3.56B
| $5.73M | ﹤0.01% |
272,660
-30,485
| -10% | -$585K |
|
1650
Knowles
KN
$3.34B
| $5.72M | ﹤0.01% |
324,633
+86,076
| +36% | +$1.39M |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.